-
1
-
-
0025369970
-
The measurement and mechanism of lipid peroxidation in biological systems
-
Gutteridge J.M.C., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 15:1990;129-135.
-
(1990)
Trends Biochem. Sci.
, vol.15
, pp. 129-135
-
-
Gutteridge, J.M.C.1
Halliwell, B.2
-
2
-
-
0029982815
-
Oxidative damage in Alzheimer's
-
Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
-
(1996)
Nature
, vol.382
, pp. 120-121
-
-
Smith, M.A.1
Perry, G.2
Richey, P.L.3
Sayre, L.M.4
Anderson, V.E.5
Beal, M.F.6
Kowall, N.7
-
3
-
-
0036710931
-
Lipid peroxidation in aging brain and Alzheimer's disease
-
Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts L.J. II, Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 33:2002;620-626.
-
(2002)
Free Radic. Biol. Med.
, vol.33
, pp. 620-626
-
-
Montine, T.J.1
Neely, M.D.2
Quinn, J.F.3
Beal, M.F.4
Markesbery, W.R.5
Roberts L.J. II6
Morrow, J.D.7
-
4
-
-
13144259660
-
2-isoprostanes in biological fluids and tissues as measure of oxidant stress
-
2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 300:1999;3-12.
-
(1999)
Methods Enzymol.
, vol.300
, pp. 3-12
-
-
Morrow, J.D.1
Roberts L.J. II2
-
5
-
-
0032577553
-
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid
-
Roberts L.J. II, Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 13605-13612
-
-
Roberts L.J. II1
Montine, T.J.2
Markesbery, W.R.3
Tapper, A.R.4
Hardy, P.5
Chemtob, S.6
Dettbarn, W.D.7
Morrow, J.D.8
-
6
-
-
0034745018
-
2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and age-matched controls
-
2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and age-matched controls. Arch. Pathol. Lab. Med. 125:2001;510-512.
-
(2001)
Arch. Pathol. Lab. Med.
, vol.125
, pp. 510-512
-
-
Montine, T.J.1
Kaye, J.A.2
Montine, K.S.3
McFarland, L.4
Morrow, J.D.5
Quinn, J.F.6
-
7
-
-
0032588611
-
2-isoprostane concentration in probable AD
-
2-isoprostane concentration in probable AD. Neurology. 52:1999;562-565.
-
(1999)
Neurology
, vol.52
, pp. 562-565
-
-
Montine, T.J.1
Beal, M.F.2
Cudkowicz, M.E.3
O'Donnell, H.4
Margolin, R.A.5
McFarland, L.6
Bachrach, A.F.7
Zackert, W.E.8
Roberts, L.J.9
Morrow, J.D.10
-
8
-
-
0033596751
-
2-isoprostanes are elevated in Huntington's disease
-
2-isoprostanes are elevated in Huntington's disease. Neurology. 52:1999;1104-1105.
-
(1999)
Neurology
, vol.52
, pp. 1104-1105
-
-
Montine, T.J.1
Beal, M.F.2
Robertson, D.3
Cudkowicz, M.E.4
Biaggioni, I.5
O'Donnell, H.6
Zackert, W.E.7
Roberts, L.J.8
Morrow, J.D.9
-
11
-
-
0027287840
-
Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons
-
Moore S.A. Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons. Adv. Exp. Med. Biol. 331:1993;229-233.
-
(1993)
Adv. Exp. Med. Biol.
, vol.331
, pp. 229-233
-
-
Moore, S.A.1
-
13
-
-
0030963753
-
The isoprostanes: Unique bioactive products of lipid peroxidation
-
Morrow J.D., Roberts L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36:1997;1-21.
-
(1997)
Prog. Lipid Res.
, vol.36
, pp. 1-21
-
-
Morrow, J.D.1
Roberts, L.J.2
-
14
-
-
0024456653
-
Effect of deprenyl on the progression of disability in early Parkinson's disease
-
The Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. New Engl J Med 1989;321:1364-71.
-
(1989)
New Engl J Med
, vol.321
, pp. 1364-1371
-
-
-
15
-
-
0030967165
-
A controlled trial of selegiline, alpha-tocopherol, or both as a treatment for Alzheimer's disease
-
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ for the Members of the Alzheimer's Disease Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as a treatment for Alzheimer's disease. New Engl J Med 1997;336:1216-22.
-
(1997)
New Engl J Med
, vol.336
, pp. 1216-1222
-
-
Sano, M.1
Ernesto, C.2
Thomas, R.G.3
Klauber, M.R.4
Schafer, K.5
Grundman, M.6
Woodbury, P.7
Growdon, J.8
Cotman, C.W.9
Pfeiffer, E.10
Schneider, L.S.11
Thal, L.J.12
-
16
-
-
0035882360
-
Interactions between apolipoprotein E gene and dietary α-tocopherol influence cerebral oxidative damage in aged mice
-
Reich E., Montine K.S., Gross M.D., Roberts L.J., Swift L.L., Morrow J.D., Montine T.M. Interactions between apolipoprotein E gene and dietary α-tocopherol influence cerebral oxidative damage in aged mice. J. Neurosci. 21:2001;5993-5999.
-
(2001)
J. Neurosci.
, vol.21
, pp. 5993-5999
-
-
Reich, E.1
Montine, K.S.2
Gross, M.D.3
Roberts, L.J.4
Swift, L.L.5
Morrow, J.D.6
Montine, T.M.7
-
17
-
-
0002006158
-
Docosahexaenoic acid: Membrane function and metabolism
-
Simopoulos AP, Kifer RR, Martin RE, editors. New York: Academic Press
-
Salem N, Kim HY, Yergey JA. Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos AP, Kifer RR, Martin RE, editors. Health effects of polyunsaturated acids in seafoods. New York: Academic Press; 1986. p. 263-317.
-
(1986)
Health Effects of Polyunsaturated Acids in Seafoods
, pp. 263-317
-
-
Salem, N.1
Kim, H.Y.2
Yergey, J.A.3
-
18
-
-
0033031276
-
Coexistence of oxidized lipids and α-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques
-
Niu X., Zammit V., Upston J.M., Dean R.T., Stocker R. Coexistence of oxidized lipids and α-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 19:1999;1708-1718.
-
(1999)
Arterioscler. Thromb. Vasc. Biol.
, vol.19
, pp. 1708-1718
-
-
Niu, X.1
Zammit, V.2
Upston, J.M.3
Dean, R.T.4
Stocker, R.5
-
19
-
-
0032513141
-
Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol
-
Garner B., Witting P.K., Wakdeck A.R., Christison J.K., Raftery M., Stocker R. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol. J. Biol. Chem. 273:1998;6080-6087.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 6080-6087
-
-
Garner, B.1
Witting, P.K.2
Wakdeck, A.R.3
Christison, J.K.4
Raftery, M.5
Stocker, R.6
-
20
-
-
0025058849
-
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids
-
Morrow J.D., Harris T.M., Roberts L.J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184:1990;1-10.
-
(1990)
Anal. Biochem.
, vol.184
, pp. 1-10
-
-
Morrow, J.D.1
Harris, T.M.2
Roberts, L.J.3
-
21
-
-
0024587229
-
2α by aldehyde reductase from human liver: Comparison to the prostaglandin F synthetase from bovine lung
-
2α by aldehyde reductase from human liver: comparison to the prostaglandin F synthetase from bovine lung. J. Biol. Chem. 264:1989;1036-1040.
-
(1989)
J. Biol. Chem.
, vol.264
, pp. 1036-1040
-
-
Hayashi, H.1
Fujii, Y.2
Watanabe, K.3
Urade, Y.4
Hayaishi, O.5
|